Dr John T Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, Interdisciplinary Stem Cell Institute.
University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Regen Med. 2022 Aug;17(8):581-595. doi: 10.2217/rme-2022-0043. Epub 2022 Jun 7.
The past decades witnessed the slow evolution of Europe's heterogeneous stem cell (SC) policy and substantial scientific advances in the field. Parallel to these developments, professional organizations have grown in influence. With the recently revised International Society for Stem Cell Research's Guidelines as a backdrop, we address the evolution of SC policies in 46 European countries and discuss how they fare against evolving ethical standards, societal views, and scientific advances. We identify areas of convergence, divergence, and the suitability of extant governance mechanisms to meet their stewardship roles. Europe represents a rich case study as it encompasses a wide range of policy approaches present worldwide. Comparative studies provide an opportunity to promote insight into national frameworks and to foster international harmonization.
过去几十年见证了欧洲异质干细胞 (SC) 政策的缓慢演变和该领域的重大科学进步。与这些发展并行的是，专业组织的影响力不断增强。以最近修订的国际干细胞研究学会指南为背景，我们探讨了 46 个欧洲国家的 SC 政策演变，并讨论了它们如何应对不断变化的伦理标准、社会观点和科学进步。我们确定了趋同、分歧的领域，以及现有治理机制在履行其管理职责方面的适宜性。欧洲是一个很好的案例研究，因为它包含了世界范围内广泛存在的各种政策方法。比较研究提供了一个机会，可以深入了解国家框架，并促进国际协调。
